Sensitivity, specificity, and accuracy of a liquid biopsy approach utilizing molecular amplification pools
Abstract Circulating cell-free DNA (cfDNA) has the potential to be a specific biomarker for the therapeutic management of lung cancer patients. Here, a new sequencing error-reduction method based on molecular amplification pools (MAPs) was utilized to analyze cfDNA in lung cancer patients. We determ...
Guardado en:
Autores principales: | Jessica Garcia, Nick Kamps-Hughes, Florence Geiguer, Sébastien Couraud, Brice Sarver, Léa Payen, Cristian Ionescu-Zanetti |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/da8aee7bdc1c403a8d63c53a6d8142ba |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Diagnostic Accuracy of Liquid Biopsy in Endometrial Cancer
por: Marta Łukasiewicz, et al.
Publicado: (2021) -
Clinical utility of liquid biopsy for the diagnosis and monitoring of EML4-ALK NSCLC patients
por: Sánchez-Herrero Estela, et al.
Publicado: (2020) -
Transoral flexible laryngoscope biopsy: Safety and accuracy
por: Nabeel Humayun Hassan, et al.
Publicado: (2019) -
Liquid Biopsy and Primary Brain Tumors
por: Robert H. Eibl, et al.
Publicado: (2021) -
Liquid biopsy. A challenge for clinical laboratories
por: Jiménez Wladimiro
Publicado: (2020)